萬豐奧威(002085.SZ)一季度淨利潤預增35%-40%(追溯調整後)
格隆匯 4 月 12日丨萬豐奧威(002085.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤16556.55萬元-17169.75萬元,同比增長35%-40%(追溯調整後)。
受全球疫情影響公司2020年一季度經營業績基數較低,2021年一季度公司汽車金屬輕量化零部件板塊業務與去年同期相比有較大幅度恢復性提升;另一方面,通航飛機制造業務國外私人飛機市場業務增加及國內培訓教練機市場份額的增長,致使公司2021年一季度經營業績同比較大幅度提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.